title: Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI.
abstract: Ovarian cancer is the most lethal among the gynecologic malignancies with approximately 70% of patients presenting with advanced tumor stage. The prognosis of patients with ovarian cancer is directly related to the tumor stage and residual tumor burden after cytoreductive surgery. Exploratory laparotomy has been the cornerstone in the management of ovarian cancer, as it offers staging and tumor debulking. Understaging at initial laparotomy, however, is a problem in up to 30%, mainly due to insufficient technique and unexpected peritoneal spread outside the pelvis. Sites difficult to assess intraoperatively including the posterior aspect of the liver and the dome of the diaphragm can be well demonstrated with multiplanar imaging. CT and alternatively MRI have been accepted as adjunct imaging modalities for preoperative staging ovarian cancer. Of these, multidetector CT is the imaging modality of choice for staging ovarian cancer. In a multidisciplinary team approach patient management may be guided towards an individualized treatment plan. The contribution of imaging includes (1) surgery planning including referral practice, (2) selection of candidates for primary chemotherapy by demonstration of non (optimally) resectable disease, and (3) tissue sampling in peritoneal carcinomatosis.
authors: Universitätsinstitut für Radiodiagnostik, Müllner Hauptstr. 48, A-5020, Salzburg, Austria. R.Forstner@salk.at
authors: Rosemarie
authors: R
authors: Forstner
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis; D001706:Biopsy; D003287:Contrast Media; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008279:Magnetic Resonance Imaging; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000628:therapy; D018579:Patient Selection; D014057:Tomography, X-Ray Computed
chemical_list: D014408:Biomarkers, Tumor; D003287:Contrast Media
references: Radiology. 2000 Jun;215 Suppl:861-71
references: 11037511
references: Radiology. 1999 Jul;212(1):19-27
references: 10405715
references: Obstet Gynecol Surv. 2007 Jan;62(1):58-72
references: 17176489
references: Radiol Clin North Am. 2002 May;40(3):609-36
references: 12117196
references: J Cancer Res Clin Oncol. 2002 Mar;128(3):153-60
references: 11935302
references: Gynecol Oncol. 1993 Nov;51(2):150-4
references: 8276287
references: Clin Radiol. 1997 Sep;52(9):692-7
references: 9313735
references: J Clin Oncol. 1993 Jan;11(1):166-72
references: 8418230
references: Crit Rev Oncol Hematol. 2006 Nov;60(2):159-79
references: 17018256
references: Br J Radiol. 2005;78 Spec No 2:S94-102
references: 16306641
references: Cancer. 2000 Oct 1;89(7):1532-40
references: 11013368
references: Gynecol Oncol. 2005 Nov;99(2):447-61
references: 16126262
references: Obstet Gynecol Surv. 2005 May;60(5):326-30
references: 15841027
references: Radiology. 2005 Jun;235(3):918-26
references: 15914479
references: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references: 15761078
references: Br J Cancer. 2001 Sep 28;85(7):944-52
references: 11592763
references: Gynecol Oncol. 1988 May;30(1):7-14
references: 2452773
references: Radiology. 2004 Nov;233(2):433-40
references: 15516617
references: J Comput Assist Tomogr. 1986 Nov-Dec;10 (6):937-41
references: 3782563
references: Int J Gynecol Cancer. 2005 Mar-Apr;15(2):377-81
references: 15823129
references: Cancer. 2001 Jun 15;91(12):2329-34
references: 11413522
references: Hum Reprod. 1989 Jan;4(1):1-12
references: 2651469
references: Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:108-10
references: 16515576
references: Semin Surg Oncol. 2000 Jul-Aug;19(1):3-10
references: 10883018
references: Crit Rev Oncol Hematol. 2004 Jan;49(1):77-86
references: 14734157
references: Clin Cancer Res. 2005 May 15;11(10):3686-96
references: 15897565
references: Obstet Gynecol. 2006 Jan;107(1):77-85
references: 16394043
references: Int J Gynecol Cancer. 2005 May-Jun;15 Suppl 1:3-11
references: 15839952
references: Gynecol Oncol. 2003 Sep;90(3):519-28
references: 13678719
references: Gynecol Oncol. 1983 Aug;16(1):95-100
references: 6884834
references: Curr Treat Options Oncol. 2001 Apr;2(2):109-18
references: 12057129
references: Gynecol Oncol. 1997 Jun;65(3):467-72
references: 9190977
references: Gynecol Oncol. 2005 Nov;99(2):294-300
references: 16051330
references: J Clin Oncol. 2005 Apr 20;23(12):2813-21
references: 15837995
references: Radiology. 1997 Aug;204(2):513-20
references: 9240546
references: Radiology. 2002 May;223(2):495-9
references: 11997559
references: Radiology. 2000 Jun;215(3):761-7
references: 10831697
references: Radiology. 2001 Apr;219(1):229-35
references: 11274562
references: Radiographics. 2004 Jan-Feb;24(1):225-46
references: 14730048
references: Radiology. 2003 Jul;228(1):157-65
references: 12832579
references: Radiology. 1986 Mar;158(3):649-52
references: 3945732
references: Radiology. 2001 Oct;221(1):173-7
references: 11568336
references: AJR Am J Roentgenol. 2004 Jan;182(1):227-33
references: 14684544
references: Radiology. 2005 Jul;236(1):85-94
references: 15955864
references: Zentralbl Gynakol. 2005 Feb;127(1):9-17
references: 15702446
references: Gynecol Oncol. 2005 Feb;96(2):301-6
references: 15661212
references: Eur Radiol. 2003 Dec;13 Suppl 4:L87-104
references: 15018172
references: J Clin Oncol. 2002 Mar 1;20(5):1248-59
references: 11870167
references: Gynecol Oncol. 2002 Oct;87(1):77-83
references: 12468346
references: Radiographics. 2003 May-Jun;23 (3):687-701
references: 12740470
references: Radiology. 1995 Dec;197(3):619-26
references: 7480729
references: Eur Radiol. 2003 May;13(5):943-9
references: 12695813
references: Gynecol Oncol. 1994 Apr;53(1):33-7
references: 8175019